PUNAM MALIK, MD
Medical Practice in Cincinnati, OH
License number
Ohio 35.091275
Category
Medical Practice
Type
Pediatric Hematology-Oncology
Address
Address
3333 Burnet Ave. Ml, Cincinnati, OH 45229
Phone
(513) 636-4266
(513) 636-3549 (Fax)
(513) 636-3549 (Fax)
Organization information
See more information about PUNAM MALIK at bizstanding.comPunam Malik MD
3333 Burnet Ave #ML7015, Cincinnati, OH 45229
Industry:
Pediatric Oncologist, Pediatrician
Doing business as:
Punam Malik MD,MBBS,BS
Site:
Phone:
(513) 636-4266 (Phone)
Punam Malik
Categories:
Hospitals, Physicians & Surgeons
Professional information
Punam Malik, Cincinnati OH
Specialties:
Pediatric Hematologist / Oncologist
Address:
3333 Burnet Ave, Cincinnati, OH 45229
Education:
Bachelor of Medicine, Bachelor of Surgery*
Board certifications:
American Board of Pediatrics Sub-certificate in Pediatric Hematology/Oncology (Pediatrics)*
Punam Malik, Cincinnati OH
Specialties:
Pediatric Hematology & Oncology
Address:
Cincinnati Childrns Hosp Cancer
3333 Burnet Ave STE 7015, Cincinnati 45229
(513) 636-4266 (Phone)
3333 Burnet Ave STE 7015, Cincinnati 45229
(513) 636-4266 (Phone)
Certifications:
Pediatric Oncology & Pediatric Hematology, 2000, Pediatrics, 1998
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
University of Delhi / College of Medical Sciences
Children's Hospital Of L A
University of Delhi / College of Medical Sciences
Children's Hospital Of L A
Optimization Of Determinants For Successful Genetic Correction Of Diseases, Mediated By Hematopoietic Stem Cells
US Patent:
2011029, Dec 1, 2011
Filed:
Dec 6, 2010
Appl. No.:
12/928302
Inventors:
Johannes Christiaan Maria Van Der Loo - Loveland OH, US
Dao Pan - Cincinnati OH, US
Punam Malik - Cincinnati OH, US
Dao Pan - Cincinnati OH, US
Punam Malik - Cincinnati OH, US
Assignee:
Cincinnati Children's Hospital Medical Center - Cincinnati OH
International Classification:
C12Q 1/68, C07H 21/00, C12N 15/63
US Classification:
435 61, 4353201, 536 241
Abstract:
Methods and compositions disclosed herein generally relates to methods of determining minimum hematopoietic stem cell (HSC) chimerism and gene dosage for correction of a hematopoietic disease; in particular, in in vivo models. The invention also relates to modified lentiviral expression vectors for increase a viral titer and various methods for increasing such titers as well as expression vectors capable of enhancing such titers. The invention also relates to CHS4 chromatin insulator-derived functional insulator sequences. The invention further relates to methods for genetic correction of diseases or reducing symptoms thereof, such as sickle cell anemia, a lysosomal storage disease. The invention further relates to a method of improving and/or correcting one or more central nervous system (CNS) abnormalities caused by one or more lysosomal storage disease. The invention further relates to methods of improving titer in transfection-based bioreactor culture production or transfection-based production systems using eukaryotic cells.